Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
The properties of a human monoclonal antibody to the thyrotropin receptor (TSHR) (M22) with the characteristics of patient sera thyroid stimulating autoantibodies is described. Similar concentrations (pmol/L) of M22 Fab and porcine TSH had similar stimulating effects on cyclic adenosine monophosphate (cAMP) production in TSHR-transfected Chinese hamster ovary cells whereas higher doses of intact M22 immunoglobulin G (IgG) were required to cause the same level of stimulation. Patient sera containing TSHR autoantibodies with TSH antagonist (blocking) activity inhibited M22 Fab and IgG stimulation in a similar way to their ability to block TSH stimulation. Thyroid-stimulating monoclonal antibodies (TSmAbs) produced in mice inhibited 125I-TSH binding and 125I-M22 Fab binding to the TSHR but the mouse TSmAbs were less effective inhibitors than M22. These competition studies emphasized the close relationship between the binding sites on the TSHR for TSH, TSHR autoantibodies with TSH agonist activity, and TSHR autoantibodies with TSH antagonist activity. Recombinant M22 Fab could be produced in Escherichia coli and the recombinant and hybridoma produced Fabs were similarly active in terms of inhibition of TSH binding and cAMP stimulation. The crystal structure of M22 Fab was determined to 1.65 A resolution and is that of a standard Fab although the hypervariable region of the heavy chain protrudes further from the framework than the hypervariable region of the light chain. The M22 antigen binding site is rich in aromatic residues and its surface is dominated by acidic patches on one side and basic patches on the other in agreement with an important role for charge-charge interactions in the TSHR-autoantibody interaction.
FIRS Laboratories, RSR Limited, Cardiff, UK.
J
J
Sanders
J
J
Jeffreys
H
H
Depraetere
M
M
Evans
T
T
Richards
A
A
Kiddie
K
K
Brereton
L D K E
LD
Premawardhana
D Y
DY
Chirgadze
R
R
Núñez Miguel
T L
TL
Blundell
J
J
Furmaniak
B
B
Rees Smith
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000235:genetics* / Q000276:immunology; D001323:Autoantibodies / Q000737:chemistry* / Q000235:genetics* / Q000276:immunology; D016466:CHO Cells; D003001:Cloning, Molecular; D006224:Cricetinae; D018360:Crystallography, X-Ray; D004926:Escherichia coli; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D007457:Iodine Radioisotopes; D009500:Neutralization Tests; D017434:Protein Structure, Tertiary; D011989:Receptors, Thyrotropin / Q000276:immunology*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D013329:Structure-Activity Relationship; D013961:Thyroid Gland / Q000276:immunology; D013972:Thyrotropin / Q000493:pharmacokinetics
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D007140:Immunoglobulin Fab Fragments; D007457:Iodine Radioisotopes; D011989:Receptors, Thyrotropin; D011994:Recombinant Proteins; D013972:Thyrotropin